It is also worth noting that only amyloid abnormal participants were included in stage 4 which indicated that, for Alzheimer’s disease, wide presence of tau in the neocortex might be trigged by amyloid pathology [34]. The gene discussed is MAPT; the disease is Alzheimer disease.